期刊文献+

放射治疗转移性肝癌的临床预后因素研究

下载PDF
导出
摘要 目的探讨放射治疗转移性肝癌的临床疗效及影响预后的因素。方法随机选取我院2010年10月-2012年10月收治的转移性肝癌患者48例为研究对象,所有患者均在经动脉栓塞化疗后采用放射治疗。结果所有患者均完成了治疗的整个过程,总有效率为86.6%。后期随访,患者1年生存率为55.3%,2年生存率为36.8%。结论转移性肝癌患者采用放射治疗后,患者的生存率受适形放疗、肝内转移数量、经动脉栓塞化疗和Child-Pugh分级等因素的影响较大,而且这些预后因子是独立存在的。 Objective to explore the clinical curative effect of radiotherapy in the treatment of metastatic liver cancer and factors affecting the prognosis.Methods:randomly selected from October 2010 to October 2010 were 48 patients with metastatic liver cancer as the research object,all patients with radiation therapy.Results all patients completed the whole process of treatment,treatment the total effective rate was 86.6%.The late follow-up found that patients with 1 year survival rate was 55.3%,2 year survival rate was 36.8%.Conclusion metastatic liver cancer were treated by radiation therapy,the survival rate of patients with the conformal radiotherapy,intrahepatic metastasis number,by arterial embolism chemotherapy,and the Child-Pugh,grading is larger,the influence of such factors as and these there is independent prognostic factor.
作者 张建波
出处 《环球中医药》 CAS 2015年第S2期59-60,共2页 Global Traditional Chinese Medicine
关键词 放射治疗 转移性肝癌 临床疗效 预后因子 radiation therapy Metastatic liver cancer Clinical curative effect Prognostic factor
  • 相关文献

参考文献9

二级参考文献104

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部